Back to Search Start Over

Hox gene dysregulation in acute myeloid leukemia

Authors :
Frédéric Morel
Nathalie Douet-Guilbert
Audrey Basinko
Marc De Braekeleer
Etienne De Braekeleer
Marie-Josée Le Bris
Source :
Future Oncology. 10:475-495
Publication Year :
2014
Publisher :
Future Medicine Ltd, 2014.

Abstract

ABSTRACT: In humans, class I homeobox genes (HOX genes) are distributed in four clusters. Upstream regulators include transcriptional activators and members of the CDX family of transcription factors. HOX genes encode proteins and need cofactor interactions, to increase their specificity and selectivity. HOX genes contribute to the organization and regulation of hematopoiesis by controlling the balance between proliferation and differentiation. Changes in HOX gene expression can be associated with chromosomal rearrangements generating fusion genes, such as those involving MLL and NUP98, or molecular defects, such as mutations in NPM1 and CEBPA for example. Several miRNAs are involved in the control of HOX gene expression and their expression correlates with HOX gene dysregulation. HOX genes dysregulation is a dominant mechanism of leukemic transformation. A better knowledge of their target genes and the mechanisms by which their dysregulated expression contributes to leukemogenesis could lead to the development of new drugs.

Details

ISSN :
17448301 and 14796694
Volume :
10
Database :
OpenAIRE
Journal :
Future Oncology
Accession number :
edsair.doi.dedup.....93bb47fe29672b6f097502073e0048cc
Full Text :
https://doi.org/10.2217/fon.13.195